The Potential Role of Allergen Immunotherapy in Stepping Down Asthma Treatment
- 1 May 2017
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 5 (3) , 640-648
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- A summary of the new GINA strategy: a roadmap to asthma controlEuropean Respiratory Journal, 2015
- Impact of Inhaled Corticosteroids on Growth in Children with Asthma: Systematic Review and Meta-AnalysisPLOS ONE, 2015
- Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional studynpj Primary Care Respiratory Medicine, 2015
- The risk and outcomes of pneumonia in patients on inhaled corticosteroidsPulmonary Pharmacology & Therapeutics, 2015
- Assessing the Risks and Benefits of Step-Down Asthma Care: A Case-Based ApproachCurrent Allergy and Asthma Reports, 2015
- The Risks, Benefits, and Uncertainties of Stepping Down Asthma MedicationsThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Inhaled Corticosteroids and the Risk of Pneumonia in People With AsthmaChest, 2013
- Risks of Pneumonia in Patients with Asthma Taking Inhaled CorticosteroidsAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label studyBMC Pulmonary Medicine, 2010
- Switching asthma patients to a once-daily inhaled steroid improves compliance and reduces healthcare costsPrimary Care Respiratory Journal, 2005